RCDTF
Price
$65.44
Change
+$9.40 (+16.77%)
Updated
Jun 13 closing price
Capitalization
12.3B
RHHBY
Price
$39.58
Change
+$0.92 (+2.38%)
Updated
Aug 15 closing price
Capitalization
254.82B
66 days until earnings call
Interact to see
Advertisement

RCDTF vs RHHBY

Header iconRCDTF vs RHHBY Comparison
Open Charts RCDTF vs RHHBYBanner chart's image
Recordati Industria Chimica e Farmaceutica S.p.A
Price$65.44
Change+$9.40 (+16.77%)
Volume$300
Capitalization12.3B
Roche Holding
Price$39.58
Change+$0.92 (+2.38%)
Volume$2.44M
Capitalization254.82B
RCDTF vs RHHBY Comparison Chart in %
Loading...
RCDTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCDTF vs. RHHBY commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCDTF is a Hold and RHHBY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (RCDTF: $65.44 vs. RHHBY: $39.58)
Brand notoriety: RCDTF and RHHBY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RCDTF: 101% vs. RHHBY: 180%
Market capitalization -- RCDTF: $12.3B vs. RHHBY: $254.82B
RCDTF [@Pharmaceuticals: Major] is valued at $12.3B. RHHBY’s [@Pharmaceuticals: Major] market capitalization is $254.82B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $628.62B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCDTF’s FA Score shows that 1 FA rating(s) are green whileRHHBY’s FA Score has 1 green FA rating(s).

  • RCDTF’s FA Score: 1 green, 4 red.
  • RHHBY’s FA Score: 1 green, 4 red.
According to our system of comparison, RCDTF is a better buy in the long-term than RHHBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCDTF’s TA Score shows that 1 TA indicator(s) are bullish while RHHBY’s TA Score has 6 bullish TA indicator(s).

  • RCDTF’s TA Score: 1 bullish, 0 bearish.
  • RHHBY’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RHHBY is a better buy in the short-term than RCDTF.

Price Growth

RCDTF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while RHHBY (@Pharmaceuticals: Major) price change was +3.53% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.35%. For the same industry, the average monthly price growth was +5.72%, and the average quarterly price growth was +12.95%.

Reported Earning Dates

RHHBY is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.35% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBY($255B) has a higher market cap than RCDTF($12.3B). RCDTF has higher P/E ratio than RHHBY: RCDTF (28.70) vs RHHBY (21.71). RCDTF (17.825) and RHHBY (17.248) have similar YTD gains . RHHBY has higher annual earnings (EBITDA): 18B vs. RCDTF (819M). RHHBY has more cash in the bank: 12B vs. RCDTF (342M). RCDTF has less debt than RHHBY: RCDTF (2.47B) vs RHHBY (33B). RHHBY has higher revenues than RCDTF: RHHBY (63.5B) vs RCDTF (2.48B).
RCDTFRHHBYRCDTF / RHHBY
Capitalization12.3B255B5%
EBITDA819M18B5%
Gain YTD17.82517.248103%
P/E Ratio28.7021.71132%
Revenue2.48B63.5B4%
Total Cash342M12B3%
Total Debt2.47B33B7%
FUNDAMENTALS RATINGS
RCDTF vs RHHBY: Fundamental Ratings
RCDTF
RHHBY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
11
Undervalued
PROFIT vs RISK RATING
1..100
5893
SMR RATING
1..100
4298
PRICE GROWTH RATING
1..100
4658
P/E GROWTH RATING
1..100
3646
SEASONALITY SCORE
1..100
5575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (11) in the null industry is in the same range as RCDTF (21). This means that RHHBY’s stock grew similarly to RCDTF’s over the last 12 months.

RCDTF's Profit vs Risk Rating (58) in the null industry is somewhat better than the same rating for RHHBY (93). This means that RCDTF’s stock grew somewhat faster than RHHBY’s over the last 12 months.

RCDTF's SMR Rating (42) in the null industry is somewhat better than the same rating for RHHBY (98). This means that RCDTF’s stock grew somewhat faster than RHHBY’s over the last 12 months.

RCDTF's Price Growth Rating (46) in the null industry is in the same range as RHHBY (58). This means that RCDTF’s stock grew similarly to RHHBY’s over the last 12 months.

RCDTF's P/E Growth Rating (36) in the null industry is in the same range as RHHBY (46). This means that RCDTF’s stock grew similarly to RHHBY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCDTFRHHBY
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
55%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
49%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
44%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
52%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
19%
Bullish Trend 4 days ago
49%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
18%
Bearish Trend 4 days ago
54%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
51%
Declines
ODDS (%)
N/A
Bearish Trend 8 days ago
46%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
56%
Aroon
ODDS (%)
Bullish Trend 4 days ago
14%
Bullish Trend 4 days ago
40%
View a ticker or compare two or three
Interact to see
Advertisement
RCDTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMXT1.020.10
+10.87%
Solarmax Technology
IBP267.210.44
+0.16%
Installed Building Products
NBHC37.69-0.51
-1.34%
NATIONAL BANK HOLDINGS Corp
REP.X0.967906-0.047467
-4.67%
Augur cryptocurrency
NMG1.96-0.18
-8.41%
Nouveau Monde Graphite

RCDTF and

Correlation & Price change

A.I.dvisor tells us that RCDTF and RHHBF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RCDTF and RHHBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCDTF
1D Price
Change %
RCDTF100%
N/A
RHHBF - RCDTF
3%
Poorly correlated
+0.99%
RHHBY - RCDTF
3%
Poorly correlated
+2.38%
PTKFY - RCDTF
0%
Poorly correlated
+1.99%
PTKFF - RCDTF
0%
Poorly correlated
N/A
SNPHY - RCDTF
-0%
Poorly correlated
+1.09%
More

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
+2.38%
RHHVF - RHHBY
66%
Loosely correlated
+4.32%
RHHBF - RHHBY
36%
Loosely correlated
+0.99%
ABBV - RHHBY
21%
Poorly correlated
+0.98%
JNJ - RHHBY
20%
Poorly correlated
+1.10%
CHGCY - RHHBY
20%
Poorly correlated
+2.36%
More